Aehr Test Systems Reports Strong Bookings and Raises Full-Year Revenue Guidance
summarizeSummary
Aehr Test Systems announced its Q3 fiscal 2026 results, reporting strong bookings and a high book-to-bill ratio, leading to an upward revision of its full-year revenue and second-half bookings guidance, despite current quarter losses.
check_boxKey Events
-
Strong Quarterly Bookings
Aehr Test Systems reported $37.2 million in bookings for Q3 fiscal 2026, achieving a book-to-bill ratio exceeding 3.5x, driven by demand in AI and data center infrastructure.
-
Raised Fiscal Year Guidance
The company updated its full-year fiscal 2026 revenue guidance to the high side of $45 million to $50 million and its second-half bookings guidance to the high end of $60 million to $80 million.
-
Increased Net Loss
Aehr Test Systems reported a GAAP net loss of $(3.2) million, or $(0.10) per diluted share, and a non-GAAP net loss of $(1.5) million, or $(0.05) per diluted share, for the quarter.
-
Fiscal Year End Change
The Board approved an administrative change in the fiscal year end from May 31 to June 30, effective fiscal year 2027.
auto_awesomeAnalysis
The company's third-quarter results present a mixed picture with increased net losses and lower revenue compared to the prior year. However, the significant quarterly bookings of $37.2 million, resulting in a robust book-to-bill ratio of over 3.5x, indicate strong future demand, particularly in AI, data center, and silicon photonics applications. The upward revision of full-year fiscal 2026 revenue and second-half bookings guidance to the high end of previous ranges signals management's confidence in future growth. This forward-looking strength in bookings and guidance is likely to be a key driver for investor sentiment, overshadowing the current quarter's GAAP losses and extending the company's cash runway.
At the time of this filing, AEHR was trading at $48.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $6.27 to $53.10. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.